Two Sigma Investments
TERN

Two Sigma Investments’s Terns Pharmaceuticals TERN Stock Holding History

Two Sigma Investments’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.87M Buy
54,366
+10,500
+24% +$431K ﹤0.01% 2473
2025
Q4 		$1.77M Buy
43,866
+9,836
+29% +$227K ﹤0.01% 2527
2025
Q3 		$256K Sell
34,030
-170,927
-83% -$1.09M ﹤0.01% 3291
2025
Q2 		$764K Buy
204,957
+77,485
+61% +$242K ﹤0.01% 2386
2025
Q1 		$352K Buy
127,472
+32,783
+35% +$134K ﹤0.01% 2651
2024
Q4 		$525K Sell
94,689
-49,567
-34% -$336K ﹤0.01% 2517
2024
Q3 		$1.2M Buy
144,256
+82,833
+135% +$682K ﹤0.01% 2016
2024
Q2 		$418K Buy
+61,423
New +$372K ﹤0.01% 2448

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Two Sigma Investments's TERN Position: Q1 2026 in Review

Two Sigma Investments increased its Terns Pharmaceuticals (TERN) stake by 24% in Q1 2026, buying an estimated $431K and bringing the position to 54,366 shares worth $2.87M. The position accounts for ﹤0.01% of the portfolio, ranked #2473.

Two Sigma Investments first reported a position in TERN in Q2 2024 and has held it in 8 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Two Sigma Investments held 54,366 shares of Terns Pharmaceuticals worth $2.87M as of Q1 2026.
  • Two Sigma Investments bought 10,500 Terns Pharmaceuticals shares in Q1 2026, an estimated $431K.
  • Terns Pharmaceuticals made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #2473 holding.
  • Two Sigma Investments first reported a position in Terns Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.